Skip to content

Clinical trials

Completed Phase 2 Hypogonadism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypogonadism Phase: Phase 2 Status: Completed Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20046
20053
20066
20073
20082
20093
20102
20115
20122
20132
20141
20164
20171
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Clarus Therapeutics, Inc.5
Repros Therapeutics Inc.5
QuatRx Pharmaceuticals Company3
Acerus Pharmaceuticals Corporation2
Eli Lilly and Company2
Massachusetts General Hospital2
Mereo BioPharma2
Solvay Pharmaceuticals2
TesoRx Pharma, LLC2
ASCEND Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypogonadism46
Eunuchism6
Erectile Dysfunction3
Diabetes Mellitus, Type 22
Endocrine System Diseases2
Gonadal Disorders2
Sexual Dysfunction, Physiological2
Chronic Pain1
Diabetes Mellitus1
Dwarfism, Pituitary1

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.